Sofosbuvir in Treatment of COVID 19
NCT04460443 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-12-08
Summary
Sofosbuvir containing treatment in treatment of COVID 19 Egyptian patients
Conditions
Interventions
- DRUG
-
sofosbuvir
Sofosbuvir once daily
- DRUG
-
Sofosbuvir ledipsavir
Sofosbuvir ledipsavir once daily
- DRUG
-
Daclatasvir
Daklatasuvir tablets
Sponsors & Collaborators
-
Tanta University
lead OTHER
Principal Investigators
-
Marwa Salama, Consultant · Tanta University - Faculty of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-01
- Primary Completion
- 2021-08-01
- Completion
- 2021-08-31
Countries
- Egypt
Study Locations
More Related Trials
-
Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19)
NCT04535869 ·Status: UNKNOWN ·Phase: PHASE3
-
Remdesivir Efficacy in Coronavirus Disease
NCT04345419 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of The Efficacy of Triazavirin Versus Oseltamivir in Egyptian Patients Infected With COVID-19
NCT04973462 ·Status: UNKNOWN ·Phase: PHASE4
-
Ivermectin Nasal Spray for COVID19 Patients
NCT04510233 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Sirolimus in COVID-19 Infection
NCT04461340 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Favipiravir in Management of COVID-19
NCT04349241 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Faviprevir in COVID-19 Treatment
NCT04351295 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ivermectin and Nitazoxanide Combination Therapy for COVID-19
NCT04360356 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Ivermectin In Treatment of COVID 19 Patients
NCT04425707 ·Status: UNKNOWN ·Phase: NA
-
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
NCT04779047 ·Status: UNKNOWN ·Phase: PHASE4
-
New Antiviral Drugs for Treatment of COVID-19
NCT04392427 ·Status: UNKNOWN ·Phase: PHASE3
-
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
NCT04351347 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ivermectin in Treatment of COVID-19
NCT04445311 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19
NCT05035524 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients
NCT04738045 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
NCT04668469 ·Status: COMPLETED ·Phase: NA
-
Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience
NCT04728880 ·Status: UNKNOWN
-
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
NCT04734678 ·Status: COMPLETED
-
Antiviral Agents Against COVID-19 Infection
NCT04468087 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults
NCT04464460 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger
NCT04409483 ·Status: WITHDRAWN ·Phase: PHASE3
-
Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19
NCT04361318 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial
NCT04383717 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
NCT04449380 ·Status: TERMINATED ·Phase: PHASE2
-
To Evaluate SSD8432/Ritonavir in Adults With COVID-19
NCT05373433 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3